Drug
Low dose ASA
Low dose ASA is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)
Phase Distribution
Ph early_phase_1
1
33%
Ph phase_3
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Early Phase 1First-in-human
1(50.0%)
Phase 3Large-scale testing
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Recruiting1
Terminated1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Early Phase 11 (50.0%)
Phase 31 (50.0%)
Trials by Status
recruiting133%
terminated133%
completed133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingearly_phase_1
Identification of Critical Thermal Environments for Aged Adults
NCT04284397
terminated
PGD2 Formation in Vascular Injury
NCT01001260
completedphase_3
Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients
NCT02183688
Clinical Trials (3)
Showing 3 of 3 trials
NCT04284397Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
NCT01001260
PGD2 Formation in Vascular Injury
NCT02183688Phase 3
Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3